All
- All
- Company News
- Press Releases
Save the Date! Pharmaceutical Crystallization Summit October 14th & 15th
Cranbury, NJ, April 21,2021. J-Star Research, a leading provider of services in complex organic synthesis and crystallization for a variety of pharmaceutical clients globally, is...
2nd Edition of Fundamental of Solid Formulation (FSF2021) webinar series
CfPC is pleased to announce our collaboration in the 2nd Edition of Fundamental of Solid Formulation (FSF2021) webinar series, featuring an impressive line-up of speakers...
Porton Pharma Solutions Ltd. celebrates its 15th Anniversary
Porton Pharma Solutions Ltd. celebrates its 15th Anniversary
2020 Pharmaceutical Crystallization Summit
Cranbury, N.J., June 26, 2020 – J-Star Research, a leading provider of services in complex organic synthesis and crystallization for a variety of pharmaceutical clients...
Center for Pharma Crystallization at J-Star Research Annual Conference
Crystallization technologies are bridges between drug substances and drug products enabling consistent safety and efficacy profiles of small molecule based medicines. To fully utilize existing...
Webinar series on Solid Formulations
We are pleased to announce a 7-week #webinar series on #solid #formulations, organized by XtalPi Inc. and J-STAR Research, Inc. Leading experts will present insights into R&D workflows, strategies,...
J-Star Research Structural Elucidation and NMR Expansion
J-Star Research has recently established significant impurity isolation and structural elucidation capabilities. The R&D team is comprised of experts in identifying and characterizing low levels...
J-Star Research, Inc launches new website
South Plainfield, NJ., March 12, 2020 -- J-Star Research, Inc, the leading Contract Research Organization focused on Small Molecule Process Research and Crystallization R&D, is...
Porton and Xtalpi Announced Strategic Cooperation
March 10, 2020, Chongqing • China--XtalPi Inc.(hereafter referred to as XtalPi), an algorithm-driven AI pharmaceutical technology company, announced the signing of a strategic cooperation agreement...
Porton Completes Acquisition of J-STAR Research
CRANBURY, N.J., Wednesday April 5th, 2017—Porton Fine Chemicals, Ltd., (“Porton”, SZ 300363), a China-based contract development and manufacturing organization （CDMO） serving the global pharmaceutical industry,...
Porton USA to Acquire J-STAR Research to Expand Its Research and Development Capabilities
CRANBURY, N.J., Jan. 27, 2017 /PRNewswire/ -- Porton Fine Chemicals, Ltd., ("Porton", SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced...
